Banque Pictet Cie Sa Lowers stake in Cooper Companies Inc (COO)

Cooper Companies Inc (COO) : Banque Pictet Cie Sa reduced its stake in Cooper Companies Inc by 23.44% during the most recent quarter end. The investment management company now holds a total of 102,286 shares of Cooper Companies Inc which is valued at $18,494,332 after selling 31,310 shares in Cooper Companies Inc , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.Cooper Companies Inc makes up approximately 0.47% of Banque Pictet Cie Sa’s portfolio.

Other Hedge Funds, Including , Trexquant Investment Lp added COO to its portfolio by purchasing 4,300 company shares during the most recent quarter which is valued at $777,483. Cooper Companies Inc makes up approx 0.10% of Trexquant Investment Lp’s portfolio.Bb&t Securities boosted its stake in COO in the latest quarter, The investment management firm added 4,745 additional shares and now holds a total of 19,171 shares of Cooper Companies Inc which is valued at $3,505,801. Cooper Companies Inc makes up approx 0.05% of Bb&t Securities’s portfolio.Parkwood reduced its stake in COO by selling 539 shares or 14.75% in the most recent quarter. The Hedge Fund company now holds 3,116 shares of COO which is valued at $553,277. Cooper Companies Inc makes up approx 0.09% of Parkwood’s portfolio.Handelsbanken Fonder Ab reduced its stake in COO by selling 2,000 shares or 0.88% in the most recent quarter. The Hedge Fund company now holds 225,500 shares of COO which is valued at $40,044,290. Cooper Companies Inc makes up approx 1.59% of Handelsbanken Fonder Ab’s portfolio.

Cooper Companies Inc opened for trading at $181.22 and hit $183.87 on the upside on Friday, eventually ending the session at $183.86, with a gain of 1.37% or 2.49 points. The heightened volatility saw the trading volume jump to 3,98,065 shares. Company has a market cap of $8,908 M.

On the company’s financial health, Cooper Companies Inc reported $2.05 EPS for the quarter, beating the analyst consensus estimate by $ 0.13 according to the earnings call on Jun 2, 2016. Analyst had a consensus of $1.92. The company had revenue of $484.80 million for the quarter, compared to analysts expectations of $463.97 million. The company’s revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.72 EPS.

Many Wall Street Analysts have commented on Cooper Companies Inc. Company shares were Reiterated by Stifel on Jun 30, 2016 to “Buy”, Firm has raised the Price Target to $ 195 from a previous price target of $180 .Company shares were Reiterated by Jefferies on Jun 3, 2016 to “Buy”, Firm has raised the Price Target to $ 190 from a previous price target of $175 .

The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Company’s brands include Biofinity Avaira and MyDay and CooperSurgical Company’s brands include Advincula Arch SeeClear and Mobius.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *